LET gel-induced pharmacological anisocoria in a pediatric patient: A case report

<p dir="ltr">LET gel, composed of lidocaine (4%), epinephrine (1:2000), and tetracaine (0.5%), is a commonly used topical anesthetic agent in various dermatological procedures. It provides effective local anesthesia and vasoconstriction, making it ideal for wound closure. It gained p...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Muhammad Abd Ur Rehman (17884283) (author)
مؤلفون آخرون: Hina Akram (14778205) (author), Syed Haris Huda (17884286) (author)
منشور في: 2023
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513528405164032
author Muhammad Abd Ur Rehman (17884283)
author2 Hina Akram (14778205)
Syed Haris Huda (17884286)
author2_role author
author
author_facet Muhammad Abd Ur Rehman (17884283)
Hina Akram (14778205)
Syed Haris Huda (17884286)
author_role author
dc.creator.none.fl_str_mv Muhammad Abd Ur Rehman (17884283)
Hina Akram (14778205)
Syed Haris Huda (17884286)
dc.date.none.fl_str_mv 2023-07-01T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.visj.2023.101786
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/LET_gel-induced_pharmacological_anisocoria_in_a_pediatric_patient_A_case_report/25124393
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
LET gel
Mydriasis
Anisocoria
Local anesthetics
Wound repair
dc.title.none.fl_str_mv LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">LET gel, composed of lidocaine (4%), epinephrine (1:2000), and tetracaine (0.5%), is a commonly used topical anesthetic agent in various dermatological procedures. It provides effective local anesthesia and vasoconstriction, making it ideal for wound closure. It gained popularity in the mid-nineties, replacing TAC (tetracaine, adrenaline, and cocaine) due to its comparable efficacy, cost-effectiveness, and non-controlled drug ingredients. While LET gel has a good safety profile, it is essential for healthcare professionals, especially emergency physicians, to be aware of potential untoward events associated with its use. One of the potential side effects of its use is pupillary dilation, or mydriasis, if the gel seeps into the eyes during application. All three components of the gel are mydriatic agents. Epinephrine acts on both α- and β-receptors. It induces pupillary dilation through α-receptors-mediated sympathetic activation of dilator pupillae as well as parasympathetic activation of the sphincter pupillae by acting on β-receptors. Lidocaine and tetracaine, on the other hand, block sodium channels and block both sympathetic and parasympathetic pathways, resulting in mydriasis. As pupillary size is primarily determined by the parasympathetic supply to the sphincter pupillae, the net effect of these agents is dilation. It is important to note that lidocaine and tetracaine can also cause a loss of pupillary reflexes, which is not influenced by epinephrine. Proper technique and caution should be exercised during the application of LET gel, especially around the eyes, to minimize the risk of ocular complications. Conservative management and observation are recommended in cases without red flags of head injury to avoid unnecessary radiation exposure.</p><h2>Other Information</h2><p dir="ltr">Published in: Visual Journal of Emergency Medicine<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.visj.2023.101786" target="_blank">https://dx.doi.org/10.1016/j.visj.2023.101786</a></p>
eu_rights_str_mv openAccess
id Manara2_818f8d2f3d9d423d710dfd364771407a
identifier_str_mv 10.1016/j.visj.2023.101786
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25124393
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling LET gel-induced pharmacological anisocoria in a pediatric patient: A case reportMuhammad Abd Ur Rehman (17884283)Hina Akram (14778205)Syed Haris Huda (17884286)Biomedical and clinical sciencesClinical sciencesLET gelMydriasisAnisocoriaLocal anestheticsWound repair<p dir="ltr">LET gel, composed of lidocaine (4%), epinephrine (1:2000), and tetracaine (0.5%), is a commonly used topical anesthetic agent in various dermatological procedures. It provides effective local anesthesia and vasoconstriction, making it ideal for wound closure. It gained popularity in the mid-nineties, replacing TAC (tetracaine, adrenaline, and cocaine) due to its comparable efficacy, cost-effectiveness, and non-controlled drug ingredients. While LET gel has a good safety profile, it is essential for healthcare professionals, especially emergency physicians, to be aware of potential untoward events associated with its use. One of the potential side effects of its use is pupillary dilation, or mydriasis, if the gel seeps into the eyes during application. All three components of the gel are mydriatic agents. Epinephrine acts on both α- and β-receptors. It induces pupillary dilation through α-receptors-mediated sympathetic activation of dilator pupillae as well as parasympathetic activation of the sphincter pupillae by acting on β-receptors. Lidocaine and tetracaine, on the other hand, block sodium channels and block both sympathetic and parasympathetic pathways, resulting in mydriasis. As pupillary size is primarily determined by the parasympathetic supply to the sphincter pupillae, the net effect of these agents is dilation. It is important to note that lidocaine and tetracaine can also cause a loss of pupillary reflexes, which is not influenced by epinephrine. Proper technique and caution should be exercised during the application of LET gel, especially around the eyes, to minimize the risk of ocular complications. Conservative management and observation are recommended in cases without red flags of head injury to avoid unnecessary radiation exposure.</p><h2>Other Information</h2><p dir="ltr">Published in: Visual Journal of Emergency Medicine<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.visj.2023.101786" target="_blank">https://dx.doi.org/10.1016/j.visj.2023.101786</a></p>2023-07-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.visj.2023.101786https://figshare.com/articles/journal_contribution/LET_gel-induced_pharmacological_anisocoria_in_a_pediatric_patient_A_case_report/25124393CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/251243932023-07-01T00:00:00Z
spellingShingle LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
Muhammad Abd Ur Rehman (17884283)
Biomedical and clinical sciences
Clinical sciences
LET gel
Mydriasis
Anisocoria
Local anesthetics
Wound repair
status_str publishedVersion
title LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
title_full LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
title_fullStr LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
title_full_unstemmed LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
title_short LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
title_sort LET gel-induced pharmacological anisocoria in a pediatric patient: A case report
topic Biomedical and clinical sciences
Clinical sciences
LET gel
Mydriasis
Anisocoria
Local anesthetics
Wound repair